BetterLife Pharma Financials
| BETRF Stock | USD 0.08 0.01 9.59% |
With this module, you can analyze BetterLife financials for your investing period. You should be able to track the changes in BetterLife Pharma individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
BetterLife |
Understanding current and past BetterLife Pharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of BetterLife Pharma's financial statements are interrelated, with each one affecting the others. For example, an increase in BetterLife Pharma's assets may result in an increase in income on the income statement.
The data published in BetterLife Pharma's official financial statements typically reflect BetterLife Pharma's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving BetterLife Pharma's quantitative information. For example, before you start analyzing numbers published by BetterLife accountants, it's essential to understand BetterLife Pharma's liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
BetterLife Pharma Stock Summary
BetterLife Pharma competes with Covalon Technologies, Mosaic Immunoengineerin, and Cellectis. BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada. Betterlife Pharma operates under Biotechnology classification in the United States and is traded on OTC Exchange.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| ISIN | CA08772P2026 |
| Business Address | 1275 West 6th |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.abetterlifepharma.com |
| Phone | 778 997 1928 |
| Currency | USD - US Dollar |
BetterLife Pharma Key Financial Ratios
There are many critical financial ratios that BetterLife Pharma's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that BetterLife Pharma reports annually and quarterly.| Return On Equity | -44.17 | |||
| Return On Asset | -4.05 | |||
| Beta | 1.62 |
BetterLife Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BetterLife Pharma's current stock value. Our valuation model uses many indicators to compare BetterLife Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BetterLife Pharma competition to find correlations between indicators driving BetterLife Pharma's intrinsic value. More Info.BetterLife Pharma is rated third in return on equity category among its peers. It is rated fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BetterLife Pharma's earnings, one of the primary drivers of an investment's value.BetterLife Pharma Systematic Risk
BetterLife Pharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. BetterLife Pharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on BetterLife Pharma correlated with the market. If Beta is less than 0 BetterLife Pharma generally moves in the opposite direction as compared to the market. If BetterLife Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one BetterLife Pharma is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of BetterLife Pharma is generally in the same direction as the market. If Beta > 1 BetterLife Pharma moves generally in the same direction as, but more than the movement of the benchmark.
BetterLife Pharma December 15, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of BetterLife Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BetterLife Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of BetterLife Pharma based on widely used predictive technical indicators. In general, we focus on analyzing BetterLife OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BetterLife Pharma's daily price indicators and compare them against related drivers.
| Downside Deviation | 9.31 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 40.04 | |||
| Value At Risk | (14.29) | |||
| Potential Upside | 16.67 |
Complementary Tools for BetterLife OTC Stock analysis
When running BetterLife Pharma's price analysis, check to measure BetterLife Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BetterLife Pharma is operating at the current time. Most of BetterLife Pharma's value examination focuses on studying past and present price action to predict the probability of BetterLife Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BetterLife Pharma's price. Additionally, you may evaluate how the addition of BetterLife Pharma to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |